Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

6.39
BATS BZX Real-Time Price
As of 1:10pm ET
 +0.17 / +2.73%
Today’s Change
5.02
Today|||52-Week Range
13.30
-24.02%
Year-to-Date

Today’s Trading

Previous close6.22
Today’s open6.16
Day’s range6.16 - 6.44
Volume4,939
Average volume (3 months)876,473
Market cap$269.6M
Data as of 1:10pm ET, 08/16/2018

Growth & Valuation

Earnings growth (last year)-12.45%
Earnings growth (this year)+17.87%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.32%
P/E ratioNM
Price/Sales1,441.71
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.01-0.26%
BTXBioTime Inc+0.11+4.56%
EDGEEdge Therapeutics In...-0.00-0.10%
AGENAgenus Inc0.000.00%
Data as of 1:11pm ET, 08/16/2018

Financials

Next reporting dateNovember 7, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$185.0K
Annual profit (last year)-$91.8M
Net profit margin-49,610.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard A. Fair
Chief Financial Officer &
Treasurer
Alan A. Musso
Corporate headquarters
Houston, Texas

Forecasts